Charles River Laboratories International Inc (CRL.N)
CRL.N on New York Stock Exchange
46.27USD
4:04pm EDT
46.27USD
4:04pm EDT
Price Change (% chg)
$0.73 (+1.60%)
$0.73 (+1.60%)
Prev Close
$45.54
$45.54
Open
$46.50
$46.50
Day's High
$47.17
$47.17
Day's Low
$45.20
$45.20
Volume
267,731
267,731
Avg. Vol
127,436
127,436
52-wk High
$47.17
$47.17
52-wk Low
$33.71
$33.71
About
Charles River Laboratories International, Inc. is a global provider of solutions, which accelerate the early-stage drug discovery and development process. The focus of its business is in vivo biology; its portfolio includes research models and services required to enable in vivo drug discovery and development. The Company... (more)
Overall
| Beta: | 1.23 |
| Market Cap (Mil.): | $2,232.79 |
| Shares Outstanding (Mil.): | 49.03 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CRL.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 21.80 | 47.13 | 37.76 |
| EPS (TTM): | 2.09 | -- | -- |
| ROI: | 7.84 | -2.58 | 18.76 |
| ROE: | 17.09 | -2.66 | 19.59 |
Charles River Labs quarterly profit beats estimates
- Contract medical researcher Charles River Laboratories International Inc reported a better-than-expected quarterly profit, following the lead of rival Covance Inc , as drug companies increasingly outsource research.
Charles River Labs quarterly profit beats estimates
July 31 - Contract medical researcher Charles River Laboratories International Inc reported a better-than-expected quarterly profit, following the lead of rival Covance Inc, as drug companies increasingly outsource research.
Competitors
| Price | Change | |
|---|---|---|
| Johnson & Johnson (JNJ.N) | $93.77 | +0.27 |
| Pfizer Inc. (PFE.N) | $29.11 | -0.12 |
| Merck & Co., Inc. (MRK.N) | $48.58 | +0.41 |
| Abbott Laboratories (ABT.N) | $36.84 | +0.21 |
| Life Technologies Corp. (LIFE.OQ) | $74.78 | +0.18 |
| Vertex Pharmaceuticals Incorporated (VRTX.OQ) | $80.72 | +0.92 |
| Onyx Pharmaceuticals, Inc. (ONXX.OQ) | $134.40 | +3.10 |
| Bioanalytical Systems, Inc. (BASI.OQ) | $1.50 | +0.03 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Trading Report for (CRL). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Plunkett Research, Ltd.
|
$99.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

